Category:

PAGES TO LINK

Our ESG commitment

RNA can help tackle some of humanity’s greatest problems: Feeding everyone and keeping them healthy while protecting the planet.

Our breakthrough RNA platform allows us to quickly and efficiently develop and make a wide pipeline of solutions to some of the world’s biggest problems.

For human health, this pipeline includes vaccines for Covid and shingles and a gene therapy for sickle cell anemia.

For plant and animal health, this pipeline includes solutions to protect bees and stop fungal pathogens that often rot fruit like strawberries and grapes.

Our Colorado potato beetle product is expected to be approved in 2022, and we have a pipeline of 13 more products for human, plant, and animal health.

ESG responsibilities are core to GreenLight’s purpose

We harness the power of biology to meet the needs of the human race, plants, animals, and the planet.

Our investors, partners, and staff understand this is our purpose and know that we will always look to deliver benefits and returns that are sustainable. 

We are a team dedicated to solving some of the world’s largest problems by delivering on the full potential of RNA through our innovative platform and products. Given the scale of the challenges we face, this is the only path that is both responsible and rewarding. 

Our products aim to address some of humanity’s greatest problems: Feeding everyone and keeping them healthy while protecting the planet.

  • For food safety and security, the products we are developing aim for sustainable food production through highly selective RNA-based bio-fungicides and bio-insecticides. These solutions are designed to meet both the needs of farmers and consumers by offering effective pest management with a favorable environmental safety profile.
  • For human health, we aim to achieve equitable global access to vaccines and therapies. The Covid-19 pandemic has shown that donor-reliant vaccine distribution models will not enable global health security to be achieved. Furthermore, even outside of a global emergency situation, vaccines and therapies designed and developed for local medical needs are sorely missing, especially in remote or poor communities. Our messenger RNA platform aims to deliver a safe and efficacious response to vaccine and therapeutic needs globally, in a rapid, scalable, and affordable manner.

GreenLight’s product pipeline for agriculture, human health, and animal health is powered by a development process and proprietary platform that allows us to design and manufacture RNA-based products at a broad range of scales in a fast and cost-effective manner, making these solutions rapidly accessible. 

For agricultural products, GreenLight’s manufacturing plant in Rochester, New York, has the ability today to produce 0.5 tons/year of RNA. To our knowledge, this is the largest RNA facility by volume in the world.

We believe in doing the right thing to meet our environmental, social, and governance responsibilities.

As a public benefit corporation, we are structured and governed to prioritize our community, employees, partners, and society generally, as well as shareholders.
Underlying everything we do as a publicly traded public benefit corporation is a commitment to Environmental, Social, and Governance responsibilities. GreenLight supports the Sustainable Development Goals (SDGs).

GreenLight's contribution to the SDGs
GreenLight’s contribution to the SDGs

Environment

  • Our agricultural products degrade quickly in the environment without detrimental impact to the soil, water, or the ecosystems dependent upon them.
  • We design solutions to target only the pest that the farmer needs to control  without harming other organisms, particularly beneficial insects and pollinators, such as honeybees
  • We aim to provide effective bio-control of the microorganisms responsible for crop losses, estimated at around 30% of the world’s food supply, by developing a control for fungal pathogens.
  • We are developing RNA solutions to protect honeybees from the Varroa destructor mite. Honeybees are responsible for the pollination of more than a third of all the food we eat and a little more than 80% of the fruits, vegetables, and tree nuts crucial to feeding the planet nutritiously.

How we operate in a sustainable manner:

  • The RNA we use for our agricultural products has been produced with yeast recycled from the agriculture and food industries, using our proprietary technology.
  • We will be analyzing our policies on waste management, energy consumption, and internal operations to ensure we operate as a company aligned with our goal of protecting humans, animals, and the environment.

Social

To address unmet medical needs of underserved populations and to prepare for future pandemics, we work with every part of the world to advance the discovery, development, scale-up, and manufacturing of vaccines and therapeutics.

We aim to make RNA products more accessible to low- and middle-income countries and believe that local needs are best addressed when we partner locally from the very beginning of the product research and development process.

  • We partnered with Serum Institute of India (SII), the world’s biggest vaccine producer, to focus on providing vaccines for low- and middle-income countries. Our technology transfer will allow SII to produce GreenLight’s messenger RNA vaccines and therapeutics in India.
  • IAVI, a nonprofit scientific research organization, will advance our messenger RNA COVID-19 vaccine candidate in a Phase I clinical trial with research partners in sub-Saharan Africa.
  • We actively seek to partner with local companies in Africa, Asia, and Latin America to advance equitable access to messenger RNA vaccines and therapeutics targeting regionally prevalent diseases. These partnerships aim to develop skills and capabilities to research, develop, make, and commercialize messenger RNA products.
  • In our plant health development process, we are committed to engaging with local agencies, agricultural partners, and academic institutions to create solutions to protect regional crops from relevant pests.
  • We are establishing a global network of partnerships and workforce development to advance research and manufacturing of effective and selective solutions targeting local pests.
  • We continuously work to improve our representation of gender, race, and ethnicity at all levels, including our board, VP, and executive levels, and our efforts to date include:
  • As of March 2022, 45% of our full-time employees self-identify as female and 45% of full-time employees self-identify as a non-Caucasian racial or ethnic group.
  • 50% of our Executive team members and Senior Vice Presidents are female.
  • 40% of our Executive team identifies as a non-Caucasian racial or ethnic group (Black or African American, Hispanic or Latino, American Indian or Alaska Native, Asian or Native Hawaiian, other Pacific Islander, or two or more races or ethnic groups).
  • Women make up 40% of the C-Suite at GreenLight compared to the industry average of 24%
  • We regularly measure and share with employees information about our gender pay gap and company statistics.
  • Our employee-run resources groups focus on common priorities and areas of interest, including the LGBTQ+ community, women, community service and fundraising, wellness, and equity, diversity & inclusion.
  • The growth in representation of female and racial and ethnic minority employees at GreenLight has outpaced our overall employee population growth; our employee base has increased 61% since March 2021, whereas there was a 66% and 80% increase in representation of women and ethnic and racial minorities, respectively.
  • 46% of our employees in Research and Scientist positions are female, when women make up only 28% of the STEM workforce.

Governance

  • GreenLight went public as one of the world’s first publicly traded public benefit corporations, or PBCs. A PBC is a corporation established to prioritize community, employees, partners, and society generally as well as shareholders.
  • GreenLight’s board of directors is diverse. More than 42% of GreenLight’s board is racially and ethnically diverse—a percentage double that of the S&P 500’s 21%.[1] Additionally, 30% of our non-executive directors are women and 5 of the 7 members of our board represent members of the Asian-American, Mexican-American, Black/African American, and LGBTQ+ communities.
  • We are committed to ensuring best practices are followed when it comes to fair business arrangements with our partners and suppliers, specifically highlighting our priority of ensuring favorable arrangements for low- and middle-income partners.

Awards 

Forward Fooding’s FoodTech 500 list ranked GreenLight at #71. Described as “the world’s first definitive list of the global entrepreneurial talent at the intersection between food, technology, and sustainability,” the award recognizes GreenLight for commitment to three UN SDGs sustainable development goals (SDGs):

  • zero hunger
  • responsible consumption and production
  • sustainable life on land

The Boston Globe ranked GreenLight as 24th of 40 Top Places to Work in Massachusetts in the 2021 large company category from an employee-based survey.

We were also recognized with a cultural excellence award for our diversity, equity, and inclusion practices

By 0 Comments

a greenlight scientist notes down on a work pad at our rochester facility.

[TEST POST] Videos for investors

The top people at GreenLight explain stuff in a digestible format.

Andrey Zarur on the disadvantages of pesticides

This caption will describe the video and what its key takeaways are, plus the key facts we would like the audience to remember.

Mark Singleton on our agricultural manufacturing process

It’s important to have this description so that important videos are clearly signposted.

  • we can also
  • use bullet points
  • particularly for statistics

Dave Kennedy on legal disclaimers

Further description

By 0 Comments

a greenlight scientists uses a pipette on a workbench in a greenlight medford facility

Our rewards

Join the GreenLight revolution

At GreenLight, every team member is valued, and we want our rewards and benefits to reflect your worth. Our goal is to make it easy to take care of yourself (now, and in the future). We want to meet our employees’ diverse needs, provide flexibility, and offer security and peace of mind. We are always considering what we can add and improve upon to make the employee experience a better one. Here is just some of what GreenLight has to offer you by way of benefits and rewards:

Your health & wellness 

Highly subsidized health and dental benefits (100% company paid for some coverages), and fully paid life, long-term disability and short-term disability insurance.

We also reimburse you for a portion of your health insurance deductible, provide reimbursement for things like gym memberships, and offer a pet insurance plan for furry friends.

Your personal time 

Enjoy a competitive time-off policy (minimum of 15 days) and flexible hours. Additionally, we provide employees with a paid day each year to volunteer.

Parents & expecting parents

We know how hard it is to juggle work, all of life’s demands, while starting a family or taking care of little ones. To help make things a little easier, here are all of the benefits we offer:

  • Paid parental leave: 12 weeks for birthing parent and 6 weeks for non-birthing parent
  • Flexible paid phase-back-to-work arrangements for new parents
  • Free premium access to care.com and subsidized back-up childcare
  • Financial support for new parent work related travel arrangements

Caring for elders

We also offer subsidized back-up eldercare

Your future 

Eligible employees are able to participate in the company’s retirement plan and make pre-tax contributions to a retirement account.

Professional development

At GreenLight, we are dedicated to the professional development of every single one of our employees. We provide many opportunities for training and personal development, including offering tuition reimbursement of up to $5,250 annually.

GreenLight Biosciences
By 0 Comments

people having a conversation

Our culture

There are seven values that set our expectations for one another, individually and collectively. We take these seriously, and they guide the way GreenLight employees carry out their work, how they treat one another, and how they represent us externally.

  1. We serve.  

We are a humanity-first enterprise, harnessing the power of biology to meet the needs of the human race and the planet we inhabit. Our investors, partners, and staff understand that we will always look to deliver benefits that are long-term and returns that are sustainable. Given the scale of the challenges we face, this is the only path that is both responsible and rewarding.

  1. We have great ambition.  

We look to solve large problems for large numbers of people, including many who are historically underserved. We ask ourselves how to make a greater impact, not how to make our own lives easier. We think not only about today’s children, but about their children.

  1. We commit to science.  

Our goals may come from the heart, but our words and actions are built firmly on science, data, and truth. We relentlessly pursue clear facts and strong solutions, and call out any pretense or bias that stands in their way.

  1. We take a stand. 

Since we work in the spirit of science, we find the courage to challenge conventional thinking. Only by doing this will we arrive at the vital breakthroughs that are needed to safeguard our human future.

  1. We collaborate inclusively.  

We take on humanity-sized issues by looking at them from every angle and bringing together those who can make a difference. We strive to practice radical collaboration built on the principles of inclusion, diversity, and equality, not just because they are right but because they give us the greatest ability to push the boundaries of scientific discovery.

  1. We live in the real world. 

Our work is driven by the practical realities that people face now and tomorrow—in fields, homes, and hospitals. We work shoulder to shoulder with scientists, farmers, and doctors to deliver definitive results that support a healthier, more sustainable future.

  1. We care.  

We care for the planet, for the vast diversity of its current and future inhabitants, and for one another. To us, true care means tangible results, whether that is supporting other GreenLighters to meet personal goals or creating far-reaching access to clean food and the best healthcare.

By 0 Comments

Where we are now

We’re just getting started.

GreenLight’s 13+ years of scientific progress has led us up to a few key successes.

Platform for mRNA

GreenLight’s platform, developed through 13 years of research and technology, is protected by foundational patents. Our process know-how, and the technology we developed to produce double-stranded RNA at metric-ton scale, can be leveraged and transformed, using our technical agility, for our mRNA platform. 

7+ agricultural products in development

…with an addressable market of $6b that we plan to launch by 2026.

Demonstrated control of fungal pathogens

Control of fungal pathogens using double-stranded RNA has been demonstrated in field testing for the first time. This addresses the number one cause of food rotting. Based on this data, we have made the decision to move from discovery to development of a product to address the number one cause of food rotting. In the overall agricultural space, this represents an enormous market.

Progress for bees

Higher brood and health scores on bee colonies for our varroa mite treatment, compared to chemical controls with 2 and 8g/l application. The data from our trials to treats varroa mite infestation in beehives supports our progress toward commercialization and demonstrates that that we can acquire a product, improve upon it, and then move toward having a real-world solution that protects bees, beekeepers, and pollination-dependent crops.

A Covid-19 vaccine

We have witnessed promising antibody response and cell-mediated immunity for our GreenLight Covid-19 vaccine candidates in mice. The data indicates feasibility of initiating clinical trials in Africa for our vaccine candidate.

Bill & Melinda Gates milestone reached

Our RNA-based candidate is designed to deliver a healthy copy of the gene to stem cells. Our concept of simple injections of mRNA/lipid nanoparticle formulations is a treatment method we are actively researching with a Bill and Melinda Gates Foundation grant to develop gene therapies to treat sickle cell anemia. It’s time to move to the next phase of research.

To find out more, click here.

By 0 Comments

an aerial view of a green field

The world is in peril and aching for solutions

We are united by sustainability

Environmental and social impact is inherent to our purpose and the underlying reason our company was launched. We were founded to develop sustainable solutions for the biggest issues facing humanity and the planet. GreenLight scientists are developing new solutions for public health challenges and sustainable food production to feed a growing population. We believe our environmental, social, and governance strategy is fundamental to achieving our mission and underscores everything we do at GreenLight.

There is a need to take immediate action to address the environmental crisis that is forcing the reconsideration of how products are made, from our homes to our food, to our clothing. Many modern approaches to produce food and drugs to keep the growing population healthy have had a negative effect on the health of the planet. Clear cutting forests for cattle, chemical residues on food, in the water and in the soil, nitrogen blooms in rivers, declining soil productivity, the loss of bees and other beneficial insects—these are all clear signs that the current system is not sustainable.

The world is running out of arable soil. For years, farmers have used effective petroleum-based chemical pesticides in the form of neonicotinoids, pyrethroids, carbamates, and organophosphates. Over time, these non-targeted products can have unintended negative consequences, including damage to beneficial insects and plants, and they can linger in the environment for years, eroding soil quality and polluting water resources.

Using RNA, we can create targeted biocontrols for agriculture. Biology also offers a fundamental shift in how things are made and disposed of in a world where things grow and decay, creating circular, regenerative processes. Our goal is to have products that can help the environment, not harm it. GreenLight’s RNA is produced from natural materials using a clean enzymatic process with very little waste or harmful emissions, and after application our RNA product candidates disappear in a few days.

We aim to provide farmers with safe-to-use, cost-effective, targeted biocontrols that stop pests while protecting crops, honeybees, and land before and after harvest. If we help farmers create greener, cleaner crops, they can provide consumers with the greener, cleaner foods they demand. Additionally, we also intend to provide farmers with safer products to handle, while helping farming families promote more sustainable land for future generations.

Values and biases can be embedded in the technologies that are made, in the applications that are considered, and in the ways problems are addressed. Inclusion of those who have historically been left out of the development of new technologies is essential to building equitable and positive outcomes. GreenLight was born from a passion to make our world more sustainable and more equitable. Our vision is to enable Africa, Asia, and Latin America to meet local demand through local production. Our novel RNA manufacturing process—quick to start, built for scale, and using small bioreactors—may be part of the solution.

An ecosystem thrives with more diversity, and the inclusion of many different voices is essential to growing our company. Team members are empowered to bring their best ideas forward, and leaders are always open to listen and act. We challenge one another to discover breakthroughs that advance our science to deliver on a common cause: sustaining the planet, protecting our food, saving lives. With equity, diversity, and inclusion principles as the foundation, we are relentlessly focused on cultivating a team with diverse backgrounds and perspectives. We are always thinking about how we can better serve our colleagues of different genders, ethnicities, generations, educational achievement, sexual orientation, and workstyles. These values and initiatives are not just a top-down corporate statement; they are an intrinsic part of our culture.

By 0 Comments

a scientist holds up a glass flask in GreenLight's Rochester facility

Our manufacturing platform

Our platform, developed through 13 years of research and technology development, is protected by foundational patents that address barriers cell-free technologies have faced for many years.

Biologic production through living cells faces a range of constraints. These include the cell’s priority for self-preservation, which fights against RNA production, reducing yield and quality.

Conventional cell-free production breaks open the cells and removes the need to balance bioprocessing against self-preservation. But energy management in this method limits yield and quality, making RNA production prohibitive for many human health and most agricultural applications in terms of cost, scale, and speed.

Our proprietary cell-free process regenerates the energy needed for bioprocessing using ingredients that can include polyphosphates and enzymes.

Each step and reaction component in our bioproduction process has been developed or selected with cost, quality, safety, and commercial scalability in mind. Our technology solves many RNA production problems:

  • The key raw material for dsRNA can be obtained in large quantities from such sources as industrial fermentation processes (e.g., spent yeast material).
  • Enzymes facilitate reenergizing nucleotides. These thermally stable enzymes allow us to eliminate regulation elements, creating purer ingredients.
  • Our proprietary process allows us to energize naturally occurring nucleoside monophosphates at low cost.
By 0 Comments

a wide shot of a green field against a sky

The reason we exist

At GreenLight, we believe that the term ‘Corporate Social Responsibility’ (CSR) is no longer sufficient for us because it implies that such responsibility—doing good in the world—is separate from our core business model, when in fact it is our business model.

The following values are deeply coded within our business, mission, and culture:

  • Care for everyone
  • Courage to achieve the impossible
  • Collaboration to propel our success
  • Commitment to science and always doing the right thing

Our culture is built on care, transparency, diversity, employee ownership and engagement, and a deep, humble respect for science. Transparency is essential to how we operate, to enable sharing of the insights and tools that enable our platform to grow, as well as to build trust and accountability with all our stakeholders.

Not a typical biotech company

At GreenLight, we don’t just measure our success through innovation. What good is scientific progress if the vast majority of countries can’t benefit from it?

We are united by a common purpose: creating a more sustainable future by bringing food security, medicine, and healthcare to everyone. From the very beginning, our founders believed that the way forward would be based on equality, diversity, and inclusion. These founding principles guide us every day as we identify and develop a highly talented workforce.

Success at GreenLight is measured by impact—on those most in need, on our planet, and on our amazing team of GreenLighters who make the company what it is today.

Our primary goal is to use our research to meet the needs of the human race. This is what sets GreenLight apart, and this is what has enabled us to form teams that care more about helping others than they do about profit.

Our core mission is socially driven, which is why GreenLight Biosciences will soon be a Certified B Corporation: balancing purpose and profit in everything that we do.

Every decision we take is carefully guided by the resulting benefit it can bring.

Our public benefit mission:

“To improve public health and the environment by developing and commercializing biological products that can reduce chemicals in our environment and promote health through delivery of high-quality, affordable solutions that improve outcomes for people and the planet.”

Equity, Diversity & Inclusion

We firmly believe that the only way we can achieve our goals is by cultivating a team with diverse backgrounds and perspectives. We are always thinking about how we can create multifaceted and representative teams and how we can better serve our colleagues of different genders, ethnicities, generations, educational achievement, sexual orientation, workstyles, and more. 

We already have a lot to be proud of as it relates to ED&I. Women and minorities are well-represented throughout the organization. According to the 2021 US census, women represent just 27% percent of the STEM workforce in the US, yet they are half of the overall workforce. While the number of women working in the field of science is growing, there is still a long way to go.  To help counteract this underrepresentation, GreenLight is working hard to attract, recruit, and retain female scientists. We proactively monitor our diversity data and are always looking for areas of improvement.

As of November 2021:

  • 44% of our employees are women
  • 45% of our executive team are women.
  • Women represent 44% of our employees in STEM roles
  • 46% of our employees identify as a non-Caucasian racial or ethnic group (Black or African American, Hispanic, or Latino, American Indian or Alaska Native, Asian or Native Hawaiian, other Pacific Islander, or two or more races).

We are committed to doing our part to make real changes to address systemic bias and inequities. 

Listen to our Chief Operating Officer Carole Cobb talk about women in biotech manufacturing

Employee resource groups

GreenLight’s leadership team supports staff who are interested in forming committees focused on the things they care about, which helps create a flexible and diverse culture. We already have employee-run resources groups rallied around the following passions or commonalities:

  1. Equity, Diversity & Inclusion
  2. Wellness
  3. Women @ GreenLight
  4. RainbowLight (LGBTQ+)
  5. Fun (creating opportunities to connect)
  6. Global Community Service
By 0 Comments

two women speak in a crowd in front of a greenhouse

Why partner with GreenLight?

We seek to accelerate our development of RNA therapies, pipeline programs, preclinical studies, and manufacturing and commercial capabilities. 

We plan to design, build, and sell a portfolio of products growers can use to protect and preserve produce and animals safely and sustainably.

Our collaboration agreements include academic research institutions and strategic corporate partners spanning the agricultural, pharmaceutical, consumer goods, and energy industries. These agreements, with organizations both in plant and life sciences, each have a goal of one day taking products to commercialization.

By 0 Comments

man surrounded by factory

We won’t succeed alone

Here at GreenLight, we believe we are stronger together. With a united force, we will make a positive change across the globe.

Having dedicated, consistent partners in both academia and industry encourages us to remain scientifically imaginative and passionately focused on making a difference in the world.

The goal is to establish a successful and affordable commercial RNA marketplace. To date, we have collaborated with academic research institutions and strategic corporate partners spanning the agricultural, pharmaceutical, consumer goods, and energy industries.

Our key collaborators have the same goal of commercialized RNA.

Partner with us if you have interests in:

  • Validating research: You can use our platform to validate the impact of research and create a clear path to production.
  • Accelerating production at a reduced cost: Our platform reduces the cost of development and enables industrial-scale production (by the kilogram) for commercial RNA products.
  • Ensuring all industry standards are met: Our process can help guarantee RNA-based products are manufactured to meet the quality standards of your particular industry.
  • Advancing RNA capabilities in lower-income countries: Our vision is to enable Africa, Asia, and Latin America to meet local demand through local production.

As a partner, you will have unrestricted access to our platform which uses a clean, cell-free RNA production process. This process will inevitably lead to the development of plant and life sciences.

Improve plant sciences

Many pesticides are toxic, and some that were previously approved are now banned. With targeted biocontrol we attack the pest—not the plant or beneficial insects—to help farmers grow healthy crops with healthy yields. 

Advance life sciences

Drug companies know messenger RNA (mRNA) as an effective means to stop the spread of infectious disease. But creating vaccines is a slow process, and one that is difficult to scale. Our flexible RNA platform offers the potential for rapid vaccine production coupled with scalable, high-fidelity manufacturing. 

By 0 Comments

leaves sit on a plastic dish

Join our team

Creating mRNA in a manner which is both affordable and accessible is no easy task.

Ensuring that all communities around the world have access to its benefits is also no easy task.

Pulling this mission off for the good of humanity at a time when the world needs it the most will require a team of innovators—innovators who care about the world and one another, and who value the common good above all else.

For this very reason, we need the world’s best team.

We’re looking for the world’s best biologists, chemists, and engineers to help us solve some of the world’s most pressing challenges.

In both the agriculture and life sciences industries, GreenLight aims to bring effective solutions that are driven by rigorous scientific innovation. Your skills can help us get there.

We believe inclusion is the way forward. We celebrate the power of working together to address humanity’s challenges, meet the needs of underserved populations, and push the boundaries of scientific discovery.

Fueled by our aspiration for a true sense of belonging, our talented teams embody the principles of diversity and equality as we strive to bring food security, medicine, and healthcare to everyone—paving the way for a sustainable future.

We are committed to act boldly in doing our part to make real changes to address systemic bias and inequities.

Our open positions

We are looking to add people to our teams who have diverse skills, experiences, and education. We want team members who can develop creative solutions to challenging problems in a fast-paced and driven environment and who live by and model our values everyday.

By 0 Comments

man smiles into the camera at Rochester factory

We’re looking for the world’s best

Join our team

Creating mRNA in a manner which is both affordable and accessible is no easy task.

Ensuring that all communities around the world have access to its benefits is also no easy task.

Pulling this mission off for the good of humanity at a time when the world needs it the most will require a team of innovators—innovators who care about the world and one another, and who value the common good above all else.

For this very reason, we need the world’s best team.

We’re looking for the world’s best biologists, chemists, and engineers to help us solve some of the world’s most pressing challenges.

In both the agriculture and life sciences industries, GreenLight aims to bring effective solutions that are driven by rigorous scientific innovation. Your skills can help us get there.

We believe inclusion is the way forward. We celebrate the power of working together to address humanity’s challenges, meet the needs of underserved populations, and push the boundaries of scientific discovery.

Fueled by our aspiration for a true sense of belonging, our talented teams embody the principles of diversity and equality as we strive to bring food security, medicine, and healthcare to everyone—paving the way for a sustainable future.

We are committed to act boldly in doing our part to make real changes to address systemic bias and inequities.

Our open positions

We are looking to add people to our teams who have diverse skills, experiences, and education. We want team members who can develop creative solutions to challenging problems in a fast-paced and driven environment and who live by and model our values everyday.

By 0 Comments